MetaADEDB 2.0 @ LMMD
brinzolamide
(HCRKCZRJWPKOAR-JTQLQIEISA-N)
Structure
SMILES
COCCCN1C[C@H](NCC)c2c(S1(=O)=O)sc(c2)S(=O)(=O)N
Type(s)
Approved
ATC code(s)
S01EC04; S01EC54
Molecular Formula:
C12H21N3O5S3
Molecular Weight:
383.507
Log P:
3.2776
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
2
TPSA:
163.8
CAS Number(s):
138890-50-3; 138890-62-7
Synonym(s)
1.
brinzolamide
2.
(R)-4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-E)-1,2-thiazine-6-sulfonamide 1,1-dioxide
3.
Azopt
External Link(s)
MeSHC111827
PubChem Compound68844
BindingDB10885
ChEBI3176
CHEMBLCHEMBL220491
DrugBankDB01194
DrugCentral396
IUPHAR/BPS Guide to PHARMACOLOGY6797
KEGGcpd:C07760
dr:D00652
Therapeutic Target DatabaseD01MUR
ZINC3953037
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 119
Canada Vigilance: 1
Canada Vigilance
US FAERS
2Eye irritationFAERS: 47
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
3Eye painFAERS: 25
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
4GlaucomaFAERS: 25
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
5Visual ImpairmentFAERS: 24SIDER
US FAERS
6No adverse eventFAERS: 23US FAERS
7Product quality issueFAERS: 20US FAERS
8BlindnessFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
9Foreign body sensation in eyesFAERS: 14OFFSIDES
SIDER
US FAERS
10HeadacheFAERS: 14SIDER
US FAERS
11MalaiseFAERS: 14SIDER
US FAERS
12DizzinessFAERS: 13SIDER
US FAERS
13HypersensitivityFAERS: 13SIDER
US FAERS
14AstheniaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
15CataractFAERS: 11OFFSIDES
US FAERS
16FatigueFAERS: 11
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
17NauseaFAERS: 10SIDER
US FAERS
18Chest PainFAERS: 7SIDER
US FAERS
19Feeling abnormalFAERS: 7SIDER
US FAERS
20Incorrect dose administeredFAERS: 7US FAERS
21Medication residue presentFAERS: 7SIDER
US FAERS
22Ocular discomfortFAERS: 7SIDER
US FAERS
23PalpitationsFAERS: 7SIDER
US FAERS
24Accidental exposure to productFAERS: 6US FAERS
25AlopeciaFAERS: 6SIDER
US FAERS
26DeafnessFAERS: 6US FAERS
27EpistaxisFAERS: 6OFFSIDES
SIDER
US FAERS
28Macular degenerationFAERS: 6US FAERS
29Product dropper issueFAERS: 6US FAERS
30DysgeusiaFAERS: 5OFFSIDES
SIDER
US FAERS
31Limb injuryFAERS: 5US FAERS
32NasopharyngitisFAERS: 5OFFSIDES
SIDER
US FAERS
33Oropharyngeal painFAERS: 5OFFSIDES
SIDER
US FAERS
34Product administration errorFAERS: 5US FAERS
35PruritusFAERS: 5SIDER
US FAERS
36VertigoFAERS: 5SIDER
US FAERS
37ArthritisFAERS: 4US FAERS
38AsthmaFAERS: 4OFFSIDES
SIDER
US FAERS
39Back PainFAERS: 4SIDER
US FAERS
40BradycardiaFAERS: 4OFFSIDES
SIDER
US FAERS
41Diabetes MellitusFAERS: 4US FAERS
42DysphoniaFAERS: 4US FAERS
43Eyelid margin crustingFAERS: 4SIDER
US FAERS
44NervousnessFAERS: 4SIDER
US FAERS
45PhotophobiaFAERS: 4SIDER
US FAERS
46Punctate keratitisFAERS: 4OFFSIDES
SIDER
US FAERS
47Abdominal discomfortFAERS: 3SIDER
US FAERS
48AgitationFAERS: 3SIDER
US FAERS
49Alanine Aminotransferase IncreasedFAERS: 3US FAERS
50AnxietyFAERS: 3US FAERS
51ArthralgiaFAERS: 3SIDER
US FAERS
52ArthropathyFAERS: 3US FAERS
53Aspartate Aminotransferase IncreasedFAERS: 3US FAERS
54Cerebrovascular accidentFAERS: 3US FAERS
55Chest discomfortFAERS: 3SIDER
US FAERS
56ErythemaFAERS: 3SIDER
US FAERS
57Eye InfectionFAERS: 3US FAERS
58Eye allergyFAERS: 3SIDER
US FAERS
59KeratitisFAERS: 3SIDER
US FAERS
60Liquid product physical issueFAERS: 3US FAERS
61MyalgiaFAERS: 3SIDER
US FAERS
62OverdoseFAERS: 3US FAERS
63PolyneuropathyFAERS: 3US FAERS
64Product depositFAERS: 3US FAERS
65Productive CoughFAERS: 3US FAERS
66SyncopeFAERS: 3US FAERS
67ThrombosisFAERS: 3US FAERS
68TremorFAERS: 3SIDER
US FAERS
69VomitingFAERS: 3SIDER
US FAERS
70Weight decreasedFAERS: 3US FAERS
71WheezingFAERS: 3US FAERS
72Accidental overdoseFAERS: 2US FAERS
73AmnesiaFAERS: 2SIDER
US FAERS
74Blood pressure fluctuationFAERS: 2US FAERS
75Burning sensationFAERS: 2US FAERS
76Choking sensationFAERS: 2OFFSIDES
US FAERS
77Corneal epithelium defectFAERS: 2OFFSIDES
SIDER
US FAERS
78CryingFAERS: 2US FAERS
79DehydrationFAERS: 2OFFSIDES
US FAERS
80DiplopiaFAERS: 2SIDER
US FAERS
81Drug administration errorFAERS: 2US FAERS
82Emotional distressFAERS: 2OFFSIDES
US FAERS
83Exfoliation SyndromeFAERS: 2US FAERS
84Facial PainFAERS: 2US FAERS
85Food PoisoningFAERS: 2US FAERS
86General physical health deteriorationFAERS: 2OFFSIDES
US FAERS
87GoutFAERS: 2OFFSIDES
US FAERS
88HypotensionFAERS: 2SIDER
US FAERS
89Inappropriate schedule of drug administrationFAERS: 2US FAERS
90Joint injuryFAERS: 2US FAERS
91Macular fibrosisFAERS: 2US FAERS
92Memory impairmentFAERS: 2SIDER
US FAERS
93MonoplegiaFAERS: 2US FAERS
94Muscle tightnessFAERS: 2US FAERS
95PainFAERS: 2OFFSIDES
SIDER
US FAERS
96Product container issueFAERS: 2US FAERS
97Product packaging issueFAERS: 2US FAERS
98Product physical consistency issueFAERS: 2US FAERS
99Product use issueFAERS: 2US FAERS
100Retinal Artery OcclusionFAERS: 2US FAERS
101Retinal Vein OcclusionFAERS: 2OFFSIDES
US FAERS
102RhinitisFAERS: 2OFFSIDES
SIDER
US FAERS
103Stevens-Johnson SyndromeFAERS: 225811541CTD
OFFSIDES
US FAERS
104Suicide attemptFAERS: 2US FAERS
105Throat irritationFAERS: 2SIDER
US FAERS
106White blood cell count decreasedFAERS: 2US FAERS
107Wrong technique in product usage processFAERS: 2US FAERS
108treatment failureFAERS: 2US FAERS
109Abdominal PainFAERS: 1US FAERS
110Accidental deathFAERS: 1US FAERS
111Acute kidney injuryFAERS: 1US FAERS
112Alcohol IntoleranceFAERS: 1US FAERS
113Altered visual depth perceptionFAERS: 1US FAERS
114AphasiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
115AsphyxiaFAERS: 1US FAERS
116Atrial FibrillationFAERS: 1US FAERS
117Blood albumin decreasedFAERS: 1US FAERS
118Blood cholesterol increasedFAERS: 1US FAERS
119Breast cancer recurrentFAERS: 1US FAERS
120Bronchial HyperreactivityFAERS: 1SIDER
US FAERS
121ChokingFAERS: 1US FAERS
122Cold sweatFAERS: 1US FAERS
123Corneal erosionFAERS: 1OFFSIDES
SIDER
US FAERS
124Dacryostenosis acquiredFAERS: 1US FAERS
125Deposit eyeFAERS: 1SIDER
US FAERS
126Disease ProgressionFAERS: 1US FAERS
127Disease recurrenceFAERS: 1US FAERS
128DisorientationFAERS: 1US FAERS
129Disuse syndromeFAERS: 1US FAERS
130Documented hypersensitivity to administered drugFAERS: 1US FAERS
131Drug DependenceFAERS: 1US FAERS
132Drug administered to patient of inappropriate ageFAERS: 1US FAERS
133Drug prescribing errorFAERS: 1US FAERS
134Drug toxicityFAERS: 1US FAERS
135EczemaFAERS: 1US FAERS
136EructationFAERS: 1US FAERS
137Expired product administeredFAERS: 1US FAERS
138Extra dose administeredFAERS: 1US FAERS
139Eyelid painFAERS: 1US FAERS
140Flank PainFAERS: 1US FAERS
141FlushingFAERS: 1US FAERS
142Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
143Gastrointestinal motility disorderFAERS: 1OFFSIDES
US FAERS
144HydronephrosisFAERS: 1US FAERS
145Impaired driving abilityFAERS: 1US FAERS
146InfluenzaFAERS: 1US FAERS
147IritisFAERS: 1OFFSIDES
US FAERS
148Irritable Bowel SyndromeFAERS: 1US FAERS
149LaryngitisFAERS: 1US FAERS
150Limb discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
151Malignant HypertensionFAERS: 1US FAERS
152Mouth swellingFAERS: 1US FAERS
153Musculoskeletal PainFAERS: 1US FAERS
154Musculoskeletal stiffnessFAERS: 1US FAERS
155Myocardial InfarctionFAERS: 1US FAERS
156OverweightFAERS: 1US FAERS
157Peripheral paralysisFAERS: 1US FAERS
158Peripheral swellingFAERS: 1US FAERS
159PneumoniaFAERS: 1US FAERS
160Post-Traumatic Stress DisorderFAERS: 1US FAERS
161Product intoleranceFAERS: 1US FAERS
162Product package associated injuryFAERS: 1US FAERS
163Product packaging quantity issueFAERS: 1US FAERS
164Product storage errorFAERS: 1US FAERS
165Product substitution issueFAERS: 1US FAERS
166Product taste abnormalFAERS: 1US FAERS
167Product use complaintFAERS: 1US FAERS
168Product use in unapproved indicationFAERS: 1US FAERS
169ProteinuriaFAERS: 1US FAERS
170PsoriasisFAERS: 1US FAERS
171Retinal DegenerationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
172Retinal DetachmentFAERS: 1US FAERS
173Retinal Vascular DisorderFAERS: 1US FAERS
174Rheumatoid ArthritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
175ScabFAERS: 1SIDER
US FAERS
176SclerodermaFAERS: 1OFFSIDES
US FAERS
177SepsisFAERS: 1US FAERS
178ShockFAERS: 1US FAERS
179SinusitisFAERS: 1SIDER
US FAERS
180SneezingFAERS: 1SIDER
US FAERS
181SomnolenceFAERS: 1SIDER
US FAERS
182StressFAERS: 1US FAERS
183Superficial injury of eyeFAERS: 1US FAERS
184TachycardiaFAERS: 1SIDER
US FAERS
185TensionFAERS: 1SIDER
US FAERS
186TinnitusFAERS: 1SIDER
US FAERS
187Tooth ErosionFAERS: 1US FAERS
188Toxic Epidermal NecrolysisFAERS: 1US FAERS
189Urinary RetentionFAERS: 1US FAERS
190Urinary tract infectionFAERS: 1US FAERS
191Urinary tract obstructionFAERS: 1US FAERS
192Ventricular arrhythmiaFAERS: 1US FAERS
193Viral upper respiratory tract infectionFAERS: 1OFFSIDES
US FAERS
194Vitreous DetachmentFAERS: 1US FAERS
195Vitreous opacitiesFAERS: 1US FAERS
196Vulvovaginal burning sensationFAERS: 1US FAERS
197jaundiceFAERS: 1US FAERS
198nervous system disorderFAERS: 1SIDER
US FAERS
199Abnormal visionOFFSIDES
SIDER
200Acid refluxOFFSIDES
201Acquired diaphragmatic eventrationOFFSIDES
202Activities of daily living impairedOFFSIDES
203Acute respiratory failureOFFSIDES
204AdenocarcinomaOFFSIDES
205AgeusiaSIDER
206AmphetaminesOFFSIDES
207Angina PectorisSIDER
208ApathySIDER
209Arterial bypass operationOFFSIDES
210AsthenopiaSIDER
211AtelectasisOFFSIDES
212Biliary adenomaOFFSIDES
213Biliary dilatationOFFSIDES
214Biopsy liver abnormalOFFSIDES
215BlepharitisSIDER
216BlepharoptosisOFFSIDES
217Blood 1,25-dihydroxycholecalciferol decreasedOFFSIDES
218Blood and lymphatic system disordersSIDER
219Blood beta-D-glucan increasedOFFSIDES
220Blood chloride increasedSIDER
221Blood creatine phosphokinase abnormalOFFSIDES
222Blood parathyroid hormone increasedOFFSIDES
223Blood sodiumOFFSIDES
224Blurred visionOFFSIDES
225Bone lesionOFFSIDES
226Bone painOFFSIDES
227BronchitisSIDER
228BruxismOFFSIDES
229C-reactive protein abnormalOFFSIDES
230Cardio-respiratory distressSIDER
231Cardioactive drug level increasedOFFSIDES
232CellulitisOFFSIDES
233Cerebral artery stenosisOFFSIDES
234ChondromalaciaOFFSIDES
235Conjunctival depositOFFSIDES
236ConjunctivitisSIDER
237Corneal UlcerOFFSIDES
238Corneal epithelium disorderOFFSIDES
SIDER
239DemyelinationOFFSIDES
240Depressed moodSIDER
241DermatitisSIDER
242Diabetes InsipidusOFFSIDES
243DiscomfortSIDER
244Disturbance in sexual arousalSIDER
245DyspepsiaCanada Vigilance: 1Canada Vigilance
SIDER
246Ear and labyrinth disordersSIDER
247EndophthalmitisOFFSIDES
SIDER
248EnthesopathyOFFSIDES
249Erectile dysfunctionSIDER
250Eye inflammationOFFSIDES
251Eyelids pruritusSIDER
252Fatty LiverOFFSIDES
253Feeling jitterySIDER
254Flat affectSIDER
255FlatulenceOFFSIDES
SIDER
256Fracture treatmentOFFSIDES
257Glaucoma, Open-Angle19668763CTD
258GranulomaOFFSIDES
259IndurationOFFSIDES
260InfectionOFFSIDES
SIDER
261InfestationSIDER
262Infusion site mobility decreasedOFFSIDES
263Injection site erythemaOFFSIDES
264Injection site massOFFSIDES
265Injection site pruritusOFFSIDES
266Intestinal resectionOFFSIDES
267Intraocular pressure testOFFSIDES
268Keratoconjunctivitis SiccaSIDER
269KeratoconjunctivitisSIDER
270KeratopathySIDER
271KeratorhexisOFFSIDES
272Kidney FailureOFFSIDES
273LacrimationSIDER
274LaryngospasmOFFSIDES
275Leukopenia neonatalOFFSIDES
276Listeria sepsisOFFSIDES
277Loose toothOFFSIDES
278Lung consolidationOFFSIDES
279LymphomaOFFSIDES
280MalabsorptionOFFSIDES
281MalnutritionSIDER
282Medication residueSIDER
283MeibomianitisSIDER
284Mental status changesOFFSIDES
285Metastases to thoraxOFFSIDES
286MonoparesisOFFSIDES
287Musculoskeletal discomfortSIDER
288NeuralgiaOFFSIDES
289NocturiaOFFSIDES
290Obsessive thoughtsOFFSIDES
291Ocular Hypertension19668763CTD
292Optic AtrophyOFFSIDES
293Optic nerve cuppingSIDER
294Oral polypectomyOFFSIDES
295Oropharyngeal spasmOFFSIDES
296OrthopneaOFFSIDES
297OsteolysisOFFSIDES
298OsteopeniaOFFSIDES
299OsteoporosisOFFSIDES
300OsteosclerosisOFFSIDES
301Pancreatic InsufficiencyOFFSIDES
302PanophthalmitisOFFSIDES
303PharyngitisSIDER
304Pharyngolaryngeal PainSIDER
305Physical disabilityOFFSIDES
306PolydactylyOFFSIDES
307Prostate examination abnormalOFFSIDES
308PterygiumSIDER
309Rectal polypOFFSIDES
310Renal painSIDER
311RetinoschisisOFFSIDES
312Scleral pigmentationSIDER
313ScotomaOFFSIDES
314Secretion dischargeOFFSIDES
315Skin tightnessSIDER
316SoporOFFSIDES
317Subconjunctival cystSIDER
318Superior Vena Cava SyndromeOFFSIDES
319Synovial CystOFFSIDES
320Upper respiratory tract congestionSIDER
321Upper-airway cough syndromeSIDER
322Upset stomachSIDER
323Urethral ObstructionOFFSIDES
324UrticariaSIDER
325Venous occlusionOFFSIDES
326Visual disturbanceSIDER
327Vital dye staining cornea presentSIDER
328Vocal Cord ParalysisOFFSIDES
329effusionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.